Cas:531-47-5 5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine manufacturer & supplier

We serve Chemical Name:5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine CAS:531-47-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine

Chemical Name:5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine
CAS.NO:531-47-5
Synonyms:5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine;5,12-Dihydro-5,7,12,14-tetraazapentacen;5,12-Dihydro-5,7,12,14-tetraazapentacene;5,12-dihydrotetraazapentacene;Fluorindine;Quinoxalino[2,3-b]phenazine, 5,7,12,14-tetrahydro-;Homofluorindine
Molecular Formula:C18H14N4
Molecular Weight:286.331
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:514.0±50.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.678
PSA:63.16000
Exact Mass:286.121857
LogP:3.09

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Homofluorindine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine Use and application,5,7,12,14-Tetrahydroquinoxalino[2,3-b]phenazine technical grade,usp/ep/jp grade.


Related News: CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 5-benzyl-3-methylideneoxolan-2-one manufacturers As one analyst noted during the call, more than $1 billion in annual sales from older AZ products are now exposed to China’s volume-based procurement (VBP) initiative, a price-cutting program that targets off-patent drugs. 2-amino-4-anilino-1,3,5-triazine hydrochloride suppliers The booster campaign, with shots administered by health maintenance organisations, will effectively turn Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration (FDA). 6-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-7-methyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-5-one vendor & factory.